Victory Capital Management
MRTX

Victory Capital Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Victory Capital Management’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-7,466
Closed -$439K – 2615
2023
Q4 		$439K Buy
7,466
+400
+6% +$22.5K ﹤0.01% 2031
2023
Q3 		$308K Buy
7,066
+1,264
+22% +$45.1K ﹤0.01% 2113
2023
Q2 		$210K Sell
5,802
-134
-2% -$5.52K ﹤0.01% 2195
2023
Q1 		$221K Buy
5,936
+67
+1% +$3.01K ﹤0.01% 2225
2022
Q4 		$266K Sell
5,869
-4
-0.1% -$259 ﹤0.01% 2197
2022
Q3 		$410K Buy
+5,873
New +$435K ﹤0.01% 2142
2022
Q2 		– Sell
-108,150
Closed -$8.89M – 2767
2022
Q1 		$8.89M Buy
108,150
+17,910
+20% +$1.83M 0.01% 1153
2021
Q4 		$13.2M Buy
+90,240
New +$14M 0.01% 1048
2021
Q2 		– Sell
-93,330
Closed -$16M – 2824
2021
Q1 		$16M Sell
93,330
-296,812
-76% -$58.8M 0.02% 990
2020
Q4 		$85.7M Buy
390,142
+7,131
+2% +$1.54M 0.1% 313
2020
Q3 		$63.6M Buy
383,011
+19,551
+5% +$2.68M 0.08% 360
2020
Q2 		$41.5M Sell
363,460
-469,822
-56% -$45.6M 0.06% 492
2020
Q1 		$64.1M Buy
833,282
+409,230
+97% +$36.7M 0.05% 488
2019
Q4 		$54.6M Buy
424,052
+72,768
+21% +$7.02M 0.07% 435
2019
Q3 		$27.4M Buy
351,284
+81,494
+30% +$7.65M 0.04% 685
2019
Q2 		$27.8M Buy
+269,790
New +$21M 0.06% 498

Other funds holding MRTX

S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Victory Capital Management's MRTX Position: Q1 2024 in Review

Victory Capital Management sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2024, closing a stake of 7,466 shares — an estimated $439K sold.

Victory Capital Management first reported a position in MRTX in Q2 2019 and held it in 16 quarters. The position peaked at $85.7M in Q4 2020. 2 funds tracked by Wall St. Rank hold MRTX as of Q1 2024.

  • Victory Capital Management reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Victory Capital Management sold 7,466 Mirati Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $439K.
  • Victory Capital Management first reported a position in Mirati Therapeutics, Inc. Common Stock in Q2 2019 and held it in 16 quarters.
  • Victory Capital Management's Mirati Therapeutics, Inc. Common Stock position peaked at $85.7M in Q4 2020.
  • 2 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Victory Capital Management's 13F filing for Q1 2024, filed 3 May 2024.